Honz Pharmaceutical Co Ltd banner
H

Honz Pharmaceutical Co Ltd
SZSE:300086

Watchlist Manager
Honz Pharmaceutical Co Ltd
SZSE:300086
Watchlist
Price: 8.89 CNY 0.79% Market Closed
Market Cap: ¥4B

Honz Pharmaceutical Co Ltd
Investor Relations

Honz Pharmaceutical Co., Ltd. engages in the manufacture and distribution of drugs for children. The company is headquartered in Haikou, Hainan and currently employs 872 full-time employees. The company went IPO on 2010-05-26. The firm provides western medicines and Chinese patent drugs, including antipyretic and analgesic drugs, cold drugs, antibiotics drugs, respiratory system drugs, digestant and arresting convulsion drugs, as well as nutrition drugs, among others. The firm's products include nimesulide granules, cefminox sodium for injection, Zhike Juhong granules, Ganmao Qingre granules, artificial cow-bezoar and chlorphenamine maleate granules, cefaclor granules, carbocisteine granules, Jianerle granules, pediatric four vitaminsand calcium gluconate granules, as well as ribavirin pellets and Norfloxacin capsules for adults.

Show more
Loading
300086
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Jiangyou Hong
Chairman & Financial Director
No Bio Available
Mr. Jiangtao Hong
President
No Bio Available
Ms. Liping Hong
Vice Chairman & VP
No Bio Available
Mr. Dexin Lin
VP & Board Secretary
No Bio Available
Mr. Yong Wang
Assistant to the Chairman
No Bio Available
Yong Zhou
Accounting Supervisor
No Bio Available

Contacts

Address
HAINAN
Haikou
No. 6, Yaogu Third Road, Yaogu Industrial Park, National Hi-tech Industrial Development Zone
Contacts
+8689866812876
www.honz.com.cn
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett